A phase 1 study of crizotinib and ganetespib (STA-9090) in ALK positive lung cancers Meeting Abstract
| Authors: | Riely, G. J.; Yu, H. A.; Stephens, D.; Pietanza, M. C.; Smith-Marrone, S.; Fiore, J. J.; Goldstein, M.; Sima, C. S.; Kris, M. G.; Ginsberg, M. S. |
| Abstract Title: | A phase 1 study of crizotinib and ganetespib (STA-9090) in ALK positive lung cancers |
| Meeting Title: | 51st Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 33 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2015 May 29-Jun 2 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2015-05-20 |
| Language: | English |
| ACCESSION: | WOS:000358036901776 |
| PROVIDER: | wos |
| DOI: | 10.1200/JCO.2015.33.15_suppl.8064 |
| Notes: | Meeting Abstract: 8064 -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
